King Abdulaziz Medical City in Riyadh, the capital city of Saudi Arabia, was established by a royal decree in May 1983. With a bed capacity of 690 beds, it provides all types of care to all National Guard soldiers and their families, starting from primary health care up to tertiary specialized care.

During the past decade, King Abdulaziz Medical City conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 6 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King Abdulaziz Medical City" #1 sponsor was "National Guard Health Affairs" with 11 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 7 trials sponsored, "King Abdullah International Medical Research Center" with 7 trials sponsored, "King Abdulaziz Medical City" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King Abdulaziz Medical City" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 3 trials as a collaborator, "McMaster University" with 3 trials as a collaborator and "Monash University" with 3 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "King Abdulaziz Medical City" are "Breast Cancer" (4 trials), "Crohn Disease" (3 trials), "Acute Respiratory Distress Syndrome" (2 trials), "Breast Neoplasms" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "King Abdulaziz Medical City" in a lesser frequency.

Most popular intervention types in "King Abdulaziz Medical City" are "Drug" (32 trials), "Other" (16 trials), "Procedure" (4 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ozanimod" (3 trials), "Sodium Chloride 0.9%" (2 trials), "14 days of adequate antibiotic treatment." (1 trials) and "7 days of adequate antibiotic treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Abdulaziz Medical City" are 50 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "King Abdulaziz Medical City". 1 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in King Abdulaziz Medical City, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in King Abdulaziz Medical City, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".